LONDON--(MARKET WIRE)--Aug 16, 2007 -- TheraGenetics, an emerging personalised-medicine diagnostics company focused on central nervous system (CNS) disorders, today announced the appointments of Heiner Dreismann, Ph.D., as Chairman of the Board and Mr. Robert Forrester as Director. Dr. Dreismann most recently served as President and Chief Executive Officer of Roche Molecular Systems, Inc. (RMS), the division of Hoffmann-La Roche Ltd that pioneered clinical molecular diagnostics. Mr. Robert Forrester serves as Executive Vice President and Chief Financial Officer of CombinatoRx, Incorporated (NasdaqGM:CRXX - News) and was formerly Senior Vice President of Finance and Corporate Development at Coley Pharmaceutical Group (NasdaqGM:COLY - News).
